| CAS NO: | 2178049-58-4 |
| 包装 | 价格(元) |
| 10 mM * 1 mL in DMSO | 电议 |
| 5mg | 电议 |
| 10mg | 电议 |
| 50mg | 电议 |
| 100mg | 电议 |
| 生物活性 | ACT-1004-1239 is a potent, selective, orally availableCXCR7antagonist with anIC50value of 3.2 nM. | ||||||||||||||||
| Clinical Trial | |||||||||||||||||
| 分子量 | 522.55 | ||||||||||||||||
| 性状 | Solid | ||||||||||||||||
| Formula | C27H28F2N6O3 | ||||||||||||||||
| CAS 号 | 2178049-58-4 | ||||||||||||||||
| 运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
| 储存方式 | 4°C, sealed storage, away from moisture and light *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light) | ||||||||||||||||
| 溶解性数据 | In Vitro: DMSO : 20 mg/mL(38.27 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |
